With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The Ted Rogers Centre for Heart Research launched in 2014 after what was the largest private gift in Canadian health-care history united three world-renowned institutions: The Hospital for Sick Children, University Health Network and the University of Toronto.
Six years after visionary entrepreneur Ted Rogers died of heart failure, the Rogers family made a $130 million donation to pioneer a collaborative effort to study that same disease. It was matched by each partner, creating an unprecedented $270 million commitment to positively impact one of the most challenging chronic diseases in the world.
“Our children and I wanted to do something very meaningful in Ted’s memory,” said Loretta Rogers at the Centre’s launch in November 2014.
Heart failure took Ted from us when he was 75 years old. In the future, we want fewer Canadians to experience heart failure and allow those who do to live much longer.
At the heart of our story is “the promise of a healthy heart.” For it, we are building an person-centred approach to heart failure care and prevention – no longer a lofty ambition but instead an achievable necessity.